BIA-ALCL Epidemiological Findings From a Retrospective Study of 248 Cases Extracted From Relevant Case Reports and Series: A Systematic Review.

Aesthetic surgery journal 2023 Vol.43(5) p. 545-555

Santanelli Di Pompeo F, Panagiotakos D, Firmani G, Sorotos M

관련 도메인

Abstract

[BACKGROUND] The epidemiologic picture of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is unclear, with no high-level evidence, because only case reports and series are available.

[OBJECTIVES] The aim of this study was to update knowledge on BIA-ALCL epidemiology by utilizing all available data through a systematic review of scientific literature.

[METHODS] A search on PubMed, Scopus, and Web of Science was conducted between October 2021 and April 2022. Out of the 2799 available records, 114 pertinent articles were selected, featuring 248 BIA-ALCL cases which were retrospectively analyzed by means of descriptive statistics, incidence rate (IR), Kaplan-Meier survival curves, and Pearson correlation coefficients.

[RESULTS] The United States, the Netherlands, Italy, and Australia were the countries reporting the most cases. The mean age at first implantation was 42 years, and the mean age at diagnosis was 53 years. Aesthetic indications were the reason for 52% of cases, and reconstruction for 48%; macrotextured surface was linked to 73.8% of cases, and seroma to 83%. Total follow-up was 492 months, and mean event-free time (EFT) to BIA-ALCL development was 129 months. The IR was 96 new cases/1,000 women per year after first implantation, and was directly correlated to the number of replacements. EFT was directly correlated to the number of replacements, implant rupture, and capsule contracture, and was inversely associated with patients' age at first implantation and to BRACA1/2 and TP53 mutations.

[CONCLUSIONS] Macrotextured implant use in older patients and in patients with BRCA1/2 and TP53 mutations should be reconsidered, because this is associated with earlier disease onset. Implant replacement of asymptomatic, risk-stratified patients can be indicated due to its protective role against BIA-ALCL, reducing IR and risk, while increasing the EFT.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 bia-alcl 보형물연관 역형성대세포림프종 dict 6
해부 macrotextured surface scispacy 1
해부 breast 유방 dict 1
합병증 seroma 장액종 dict 1
합병증 implant rupture 보형물 파열 dict 1
합병증 anaplastic large cell lymphoma 보형물연관 역형성대세포림프종 dict 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [RESULTS] scispacy 1
약물 [CONCLUSIONS] Macrotextured scispacy 1
질환 breast implant-associated anaplastic large cell lymphoma C4528210
Breast implant-associated anaplastic large-cell lymphoma
scispacy 1
질환 contracture C0009917
Contracture
scispacy 1
질환 capsule scispacy 1
질환 BRCA1/2 scispacy 1
기타 women scispacy 1
기타 patients scispacy 1
기타 TP53 scispacy 1

MeSH Terms

Aged; Female; Humans; Middle Aged; Breast Implantation; Breast Implants; Breast Neoplasms; Lymphoma, Large-Cell, Anaplastic; Reoperation; Retrospective Studies

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문